As shown in Fig. S12,† the tumor-targeting efficiency of low-dose AuGNPs is 3.10% ID g−1, which is significantly higher than that of the high-dose ones (2.2% ID g−1),
thus further demonstrating that the longer blood retention of this ultrasmall glyconanoparticles significantly enhanced the tumor-targeting efficiencies through the EPR effect